McKesson buys regional drug distributor for $206M

McKesson is buying regional drug distributor D&K Healthcare for $206 million in an effort to build up its operations in the Midwest and South. McKesson -- a giant drug distributor -- is paying a 70 percent premium for the stock.

- read this AP report for more

Suggested Articles

What the NASH field needs, says Genfit CEO Pascal Prigent, is something like the Hb1Ac test for diabetes.

Blocking a newly discovered molecule produced by B cells could slow their flow into the brain and offer a new way to treat MS, a Canadian team found.

The action will see Kiadis switch its attention to earlier-stage natural killer cell therapies against solid tumors and hematological cancers.